Phibro Animal Health Corporation
PAHC
$41.88
-$1.35-3.12%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 363.89M | 378.70M | 347.83M | 309.26M | 260.43M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 363.89M | 378.70M | 347.83M | 309.26M | 260.43M |
| Cost of Revenue | 242.99M | 270.15M | 237.75M | 205.76M | 176.94M |
| Gross Profit | 120.90M | 108.55M | 110.08M | 103.50M | 83.50M |
| SG&A Expenses | 72.05M | 68.07M | 70.46M | 68.78M | 62.02M |
| Depreciation & Amortization | -- | 2.38M | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 315.04M | 340.59M | 308.21M | 274.54M | 238.96M |
| Operating Income | 48.85M | 38.10M | 39.61M | 34.73M | 21.47M |
| Income Before Tax | 36.27M | 23.85M | 29.69M | 4.84M | 9.62M |
| Income Tax Expenses | 9.74M | 6.62M | 8.81M | 1.65M | 2.65M |
| Earnings from Continuing Operations | 26.53M | 17.22M | 20.88M | 3.19M | 6.98M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 26.53M | 17.22M | 20.88M | 3.19M | 6.98M |
| EBIT | 48.85M | 38.10M | 39.61M | 34.73M | 21.47M |
| EBITDA | 61.68M | 49.09M | 52.23M | 46.30M | 30.48M |
| EPS Basic | 0.65 | 0.43 | 0.52 | 0.08 | 0.17 |
| Normalized Basic EPS | 0.52 | 0.44 | 0.55 | 0.22 | 0.24 |
| EPS Diluted | 0.65 | 0.43 | 0.51 | 0.08 | 0.17 |
| Normalized Diluted EPS | 0.52 | 0.43 | 0.55 | 0.22 | 0.24 |
| Average Basic Shares Outstanding | 40.53M | 40.50M | 40.52M | 40.50M | 40.50M |
| Average Diluted Shares Outstanding | 40.88M | 40.70M | 40.71M | 40.72M | 40.58M |
| Dividend Per Share | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 |
| Payout Ratio | 18.34% | 28.24% | 23.30% | 152.59% | 69.68% |